- Home
- GMGI vs GOSS Comparison
GMGI vs GOSS Comparison
Compare GMGI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- GOSS
- Stock Information
- Founded
- GMGI 2008
- GOSS 2015
- Country
- GMGI United States
- GOSS United States
- Employees
- GMGI N/A
- GOSS N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- GOSS Health Care
- Exchange
- GMGI Nasdaq
- GOSS Nasdaq
- Market Cap
- GMGI 261.2M
- GOSS 262.5M
- IPO Year
- GMGI N/A
- GOSS 2019
- Fundamental
- Price
- GMGI $1.72
- GOSS $1.25
- Analyst Decision
- GMGI Strong Buy
- GOSS Strong Buy
- Analyst Count
- GMGI 1
- GOSS 3
- Target Price
- GMGI $4.00
- GOSS $7.33
- AVG Volume (30 Days)
- GMGI 198.8K
- GOSS 2.6M
- Earning Date
- GMGI 08-12-2025
- GOSS 08-11-2025
- Dividend Yield
- GMGI N/A
- GOSS N/A
- EPS Growth
- GMGI N/A
- GOSS N/A
- EPS
- GMGI N/A
- GOSS N/A
- Revenue
- GMGI $168,987,998.00
- GOSS $124,590,000.00
- Revenue This Year
- GMGI $28.44
- GOSS N/A
- Revenue Next Year
- GMGI $18.24
- GOSS $91.14
- P/E Ratio
- GMGI N/A
- GOSS N/A
- Revenue Growth
- GMGI 77.72
- GOSS N/A
- 52 Week Low
- GMGI $1.33
- GOSS $0.66
- 52 Week High
- GMGI $3.10
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- GMGI 49.11
- GOSS 49.48
- Support Level
- GMGI $1.66
- GOSS $1.20
- Resistance Level
- GMGI $1.87
- GOSS $1.33
- Average True Range (ATR)
- GMGI 0.10
- GOSS 0.10
- MACD
- GMGI 0.01
- GOSS -0.02
- Stochastic Oscillator
- GMGI 52.46
- GOSS 18.37
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.